BioSphere Medical, Inc.’s (BSMD) CFO Makes Presentation at Investor Conference
Martin Joyce, CFO and executive vice president of BioSphere Medical, Inc., presented yesterday (June 17th) at Capstone Investment’s Second Annual Investor Conference in Milwaukee, Wisconsin. BioSphere Medical's main focus is the development of non-invasive diagnosis and treatment methods of uterine fibroids, using a technique known as uterine fibroid embolization. Uterine fibroids are muscular tumors that form in the wall of the uterus, and are almost always benign (non-cancerous). These often symptomless tumors most commonly affect women approximately forty to fifty years of age. At Tuesday's conference, Mr. Joyce spoke about his company's weapon against uterine fibroids, Embosphere®, noting the progress…